Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
10x Genomics, Inc. (TXG)
Price$97.74Cached quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $642.8M | $610.8M | $618.7M | $516.4M | $490.5M | $298.8M | $245.9M | $146.3M | $71.1M |
| Gross profit | $443.9M | $414.5M | $409.3M | $396.0M | $416.4M | $240.4M | $184.9M | $117.7M | $60.5M |
| Gross margin | 69.05% | 67.86% | 66.15% | 76.69% | 84.89% | 80.44% | 75.18% | 80.41% | 85.14% |
| Research & development | $238.6M | $264.7M | $270.3M | $265.7M | $211.8M | $123.4M | $83.1M | $47.5M | $32.2M |
| Operating expenses | $504.9M | $609.0M | $674.6M | $564.0M | $468.7M | $774.5M | $215.4M | $228.4M | $78.9M |
| Operating income | −$61.0M | −$194.6M | −$265.3M | −$167.9M | −$52.3M | −$534.1M | −$30.6M | −$110.8M | −$18.4M |
| Operating margin | −9.49% | −31.85% | −42.88% | −32.52% | −10.65% | −178.74% | −12.43% | −75.70% | −25.85% |
| EBITDA | −$24.8M | −$158.7M | −$229.8M | −$142.6M | −$31.1M | −$520.1M | −$23.5M | −$106.9M | −$14.1M |
| EBITDA margin | −3.86% | −25.98% | −37.14% | −27.61% | −6.35% | −174.05% | −9.56% | −73.03% | −19.79% |
| Net income | −$43.5M | −$182.6M | −$255.1M | −$166.0M | −$58.2M | −$542.7M | −$31.3M | −$112.5M | −$18.8M |
| Net profit margin | −6.77% | −29.90% | −41.23% | −32.15% | −11.87% | −181.61% | −12.71% | −76.88% | −26.39% |
| Basic EPSper basic share | -$0.35 | -$1.52 | -$2.18 | -$1.46 | -$0.53 | -$5.37 | -$0.80 | -$8.40 | -$1.62 |
| Diluted EPSper diluted share | -$0.35 | -$1.52 | -$2.18 | -$1.46 | -$0.53 | -$5.37 | -$0.80 | -$8.40 | -$1.62 |
Owners
Reported shareholders
14.67%of listed shares
FMR LLC17.63M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
FMR LLC | 14.67%17.63M shares |
BlackRock, Inc. | 8.99%10.8M shares |
ARK Investment Management LLC | 8.32%10M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 5.81%6.98M shares |
Quantinno Capital Management LP | 4.55%5.47M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.23%5.08M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 3.78%4.54M shares |
Sumitomo Mitsui Trust Group, Inc. | 3.49%4.19M shares |
Amova Asset Management Americas, Inc. | 3.49%4.19M shares |
MORGAN STANLEY | 2.79%3.35M shares |
GOLDMAN SACHS GROUP INC | 2.62%3.15M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.56%3.08M shares |
STATE STREET CORP | 2.33%2.8M shares |
CITADEL ADVISORS LLC | 2.31%2.78M shares |
DIMENSIONAL FUND ADVISORS LP | 1.85%2.23M shares |
AQR CAPITAL MANAGEMENT LLC | 1.69%2.03M shares |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1.68%2.02M shares |
Point72 Asset Management, L.P. | 1.54%1.85M shares |
Capital World Investors | 1.24%1.49M shares |
Saxonov Serge | ≈1.16%1.39M shares |
Percentages use 120.2M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 22, 2026Form 4 · 10b5-1 | Saxonov SergeChief Executive Officer | SellClass A Common Stock | 1.7K | $36.16 | $60.1K | 1.11M |
| Jun 22, 2026Form 4 · 10b5-1 | Saxonov SergeChief Executive Officer | SellClass A Common Stock | 9.8K | $35.32 | $346.9K | 1.11M |
| Jun 22, 2026Form 4 · 10b5-1 | Saxonov SergeChief Executive Officer | SellClass A Common Stock | 10.0K | $34.28 | $342.5K | 1.12M |
| Jun 22, 2026Form 4 · 10b5-1 | Saxonov SergeChief Executive Officer | SellClass A Common Stock | 8.5K | $33.29 | $283.9K | 1.13M |
| Jun 16, 2026Form 4 · 10b5-1 | SULIMAN SHEHNAAZDirector | SellClass A Common Stock | 364 | $33.27 | $12.1K | 31.7K |